Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/18474738http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/18474738http://www.w3.org/2000/01/rdf-schema#comment"

Background

The neuromyelitis optica IgG autoantibody (NMO-IgG) is a validated biomarker for NMO and an emerging spectrum of inflammatory central nervous system-demyelinating disorders. Its antigen is the astrocytic water channel aquaporin-4; NMO-IgG has not been described in a cancer context.

Objectives

To report (1) neurologic and oncologic correlates for patients incidentally identified as NMO-IgG seropositive in a blinded evaluation for paraneoplastic autoantibodies and (2) the frequency of cancer in NMO-IgG-seropositive patients.

Design

Observational, retrospective case series.

Setting

Neuroimmunology Laboratory and Neurology Clinical Practice, Mayo Clinic College of Medicine.

Patients and methods

From 1998 to 2007, we detected NMO-IgG in 2 patient groups: (1) 31 patients (88% female) identified incidentally among 180 000 patients evaluated for paraneoplastic autoantibodies and (2) 141 patients identified through physician-requested serological evaluation for a suspected NMO-spectrum disorder.

Results

In the first group, clinical information was available for 28 patients (90%). An NMO-spectrum disorder was diagnosed in 26 patients (93%), of whom 6 had a neoplasm (5 carcinomas [2 breast, 1 lung, 1 thymic, and 1 uterine cervical] and 1 B-cell lymphoma) and 1 had monoclonal gammopathy. In 4 patients, NMO-related symptoms followed neoplasia detection (median, 14 [range 3-18] months), and in 2 patients, symptoms preceded neoplasia detection (by 5 and 3 months). Two patients had carcinoma (1 breast and 1 lung) without neurological evidence of an NMO-spectrum disorder. In the second group, neoplasms were recorded in 7 seropositive patients (5.0%) with a clinically diagnosed NMO-spectrum disorder: 3 carcinomas (all breast), 1 thyroid Hürthle cell, 1 carcinoid, 1 pituitary somatotropinoma, and 1 B-cell lymphoma. An eighth patient had monoclonal gammopathy.

Conclusions

Aquaporin-4-specific IgG in some cases of NMO may reflect a paraneoplastic immune response. The clinical utility of this autoantibody as a cancer marker warrants prospective investigation."xsd:string
http://purl.uniprot.org/citations/18474738http://purl.org/dc/terms/identifier"doi:10.1001/archneur.65.5.629"xsd:string
http://purl.uniprot.org/citations/18474738http://purl.uniprot.org/core/author"Lennon V.A."xsd:string
http://purl.uniprot.org/citations/18474738http://purl.uniprot.org/core/author"Pittock S.J."xsd:string
http://purl.uniprot.org/citations/18474738http://purl.uniprot.org/core/date"2008"xsd:gYear
http://purl.uniprot.org/citations/18474738http://purl.uniprot.org/core/name"Arch Neurol"xsd:string
http://purl.uniprot.org/citations/18474738http://purl.uniprot.org/core/pages"629-632"xsd:string
http://purl.uniprot.org/citations/18474738http://purl.uniprot.org/core/title"Aquaporin-4 autoantibodies in a paraneoplastic context."xsd:string
http://purl.uniprot.org/citations/18474738http://purl.uniprot.org/core/volume"65"xsd:string
http://purl.uniprot.org/citations/18474738http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/18474738
http://purl.uniprot.org/citations/18474738http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/18474738
http://purl.uniprot.org/uniprot/#_A0A5F9ZHR4-mappedCitation-18474738http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18474738
http://purl.uniprot.org/uniprot/#_B4DHF5-mappedCitation-18474738http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18474738
http://purl.uniprot.org/uniprot/#_F1DSG4-mappedCitation-18474738http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18474738
http://purl.uniprot.org/uniprot/#_Q53H97-mappedCitation-18474738http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18474738
http://purl.uniprot.org/uniprot/#_P55087-mappedCitation-18474738http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18474738
http://purl.uniprot.org/uniprot/#_Q59GF3-mappedCitation-18474738http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18474738
http://purl.uniprot.org/uniprot/#_Q6L7A0-mappedCitation-18474738http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18474738
http://purl.uniprot.org/uniprot/#_Q9H3V7-mappedCitation-18474738http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18474738
http://purl.uniprot.org/uniprot/#_V9PBN7-mappedCitation-18474738http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/18474738
http://purl.uniprot.org/uniprot/V9PBN7http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/18474738
http://purl.uniprot.org/uniprot/Q6L7A0http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/18474738
http://purl.uniprot.org/uniprot/Q53H97http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/18474738
http://purl.uniprot.org/uniprot/P55087http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/18474738
▶